N-[3-chloro-4-(1,4,5,7-tetrahydropyrazolo[3,4-c]pyridin-6-ylmethyl)phenyl]-3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzamide

ID: ALA4640297

PubChem CID: 156014922

Max Phase: Preclinical

Molecular Formula: C29H26ClN7O

Molecular Weight: 524.03

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12

Standard InChI:  InChI=1S/C29H26ClN7O/c1-19-4-5-21(13-20(19)7-9-25-16-31-28-3-2-11-33-37(25)28)29(38)34-24-8-6-23(26(30)14-24)17-36-12-10-22-15-32-35-27(22)18-36/h2-6,8,11,13-16,22,27,35H,10,12,17-18H2,1H3,(H,34,38)

Standard InChI Key:  PCSKFQHKWWNIKM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   28.1793  -11.8286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1782  -12.6481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8862  -13.0571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5959  -12.6477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5930  -11.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8844  -11.4197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2992  -11.4137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0084  -11.8197    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2961  -10.5966    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.0023  -10.1853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4701  -13.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4715  -11.4202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7603  -11.0100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0524  -10.6017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9677   -9.7859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1682   -9.6163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3071  -10.9312    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7556  -10.3251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9594  -10.4987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7082  -11.2780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2597  -11.8842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0623  -11.7109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7068  -10.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4125  -10.1842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4098   -9.3661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6956   -8.9604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9929   -9.3733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1154   -8.9539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8252   -9.3589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5308   -8.9467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8294  -10.1761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5392  -10.5811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1215  -10.5904    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   35.2445   -9.3491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2448  -10.1689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0246  -10.4219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5063   -9.7585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0241   -9.0955    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  2 11  1  0
  1 12  1  0
 12 13  3  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 18  2  0
 17 14  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 10 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 10  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
 30 34  1  0
 31 32  1  0
 35 32  1  0
 24 33  1  0
 34 35  1  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4640297

    ---

Associated Targets(Human)

EPHB3 Tchem Ephrin type-B receptor 3 (1881 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHB2 Tchem Ephrin type-B receptor 2 (1899 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRA Tclin Platelet-derived growth factor receptor alpha (5682 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DDR2 Tchem Discoidin domain-containing receptor 2 (2199 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP4K3 Tchem Mitogen-activated protein kinase kinase kinase kinase 3 (674 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NEK6 Tchem Serine/threonine-protein kinase NEK6 (1986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 524.03Molecular Weight (Monoisotopic): 523.1887AlogP: 4.12#Rotatable Bonds: 4
Polar Surface Area: 86.92Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.43CX LogP: 4.30CX LogD: 4.25
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.39Np Likeness Score: -1.62

References

1. Kaiser TM, Dentmon ZW, Dalloul CE, Sharma SK, Liotta DC..  (2020)  Accelerated Discovery of Novel Ponatinib Analogs with Improved Properties for the Treatment of Parkinson's Disease.,  11  (4): [PMID:32292555] [10.1021/acsmedchemlett.9b00612]

Source